39, Rue Camille Desmoulins
33 09 72 22 67 08
Industry: Diagnostics & Research
Full Time Employees: 14
|Mr. Stephane Ragusa||Founder, Pres, CEO & Chairman||150k||N/A||1970|
|Mr. Émilien Gauthier||Chief Technical Officer and R&D Director||N/A||N/A||N/A|
|Marion Renelier||Legal Director||N/A||N/A||N/A|
|Anne Kerzan||Chief Marketing Officer||N/A||N/A||N/A|
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
Predilife S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.